Multiplexed and Sensitive DNA Methylation Testing Using Methylation-Sensitive Restriction Enzymes “MSRE-qPCR”

  • Gabriel Beikircher
  • Walter Pulverer
  • Manuela Hofner
  • Christa Noehammer
  • Andreas Weinhaeusel
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1708)

Abstract

DNA methylation is a chemically stable key-player in epigenetics. In the vertebrate genome the 5-methyl cytosine (5mC) has been found almost exclusively in the CpG dinucleotide context. CpG dinucleotides are enriched in CpG islands very frequently located within or close to gene promoters. Analyses of DNA methylation changes in human diagnostics have been conducted classically using methylation-sensitive restriction enzymes (MSRE). Since the discovery of bisulfite conversion-based sequencing and PCR assays, MSRE-based PCR assays have been less frequently used, although especially in the field of cancer epigenetics MSRE-based genome-wide discovery and targeted screening applications have been and are still performed successfully. Even though epigenome-wide discovery of altered DNA methylation patterns has found its way into various fields of human disease and molecular genetics research, the validation of findings upon discovery is still a bottleneck. Usually several multiples of 10 up to 100 candidate biomarkers from discovery have to be confirmed or are of interest for further work. In particular, bisulfite PCR assays are often limited in the number of candidates which can be analyzed, due to their low multiplexing capability, especially, if only small amounts of DNA are available from for example clinical specimens. In clinical research and diagnostics a similar situation arises for the analyses of cell-free DNA (cfDNA) in body fluids or circulating tumor cells (CTCs). Although tissue- or disease- (e.g., cancer) specific DNA methylation patterns can be deduced very efficiently in a genome-wide manner if around 100 ng of DNA are available, confirming these candidates and selecting target-sequences for studying methylation changes in liquid biopsies using cfDNA or CTCs remains a big challenge. Along these lines we have developed MSRE-qPCR and introduce here method details, which have been found very suitable for the efficient confirmation and testing of DNA methylation in a quantitative multiplexed manner (e.g., 48–96 plex) from ng amounts of DNA. The method is applicable in a standard qPCR setting as well for nanoliter scaled high-throughput qPCR, enabling detection of <10 copies of targets, thus suitable to pick up 0.1–1% of specific methylated DNA in an unmethylated background.

Key words

Methylation-sensitive restriction enzyme Multiplex qPCR MSRE-qPCR DNA methylation 

Notes

Acknowledgments

We thank former colleagues Rudolf Pichler, Markus Sonntagbauer, Elisabeth Reithuber, and Matthias Wielscher involved in developing and improving the described MSRE-qPCR approach. Part of this work was supported by: European Community’s Seventh Framework program EurHEALTHAgeing HEALTH-F2-2011-277849 and RESOLVE FP7-HEALTH-F4-2008-202047.

References

  1. 1.
    Daniel M, Tollefsbol TO (2015) Epigenetic linkage of aging, cancer and nutrition. J Exp Biol 218:59–70CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Shridhar K, Walia GK, Aggarwal A et al (2016) DNA methylation markers for oral pre-cancer progression: a critical review. Oral Oncol 53:1–9CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Lendvai Á, Johannes F, Grimm C et al (2012) Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics 7:1268–1278CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Noehammer C, Pulverer W, Hassler MR et al (2014) Strategies for validation and testing of DNA methylation biomarkers. Epigenomics 6:603–622CrossRefPubMedGoogle Scholar
  5. 5.
    Olkhov-Mitsel E, Bapat B (2012) Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med 1:237–260CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ståhlberg A, Zoric N, Åman P et al (2005) Quantitative real-time PCR for cancer detection: the lymphoma case. Expert Rev Mol Diagn 5:221–230CrossRefPubMedGoogle Scholar
  7. 7.
    Szita N, Polizzi K, Jaccard N et al (2010) Microfluidic approaches for systems and synthetic biology. Curr Opin Biotechnol 21:517–523CrossRefPubMedGoogle Scholar
  8. 8.
    Egger G, Wielscher M, Pulverer W et al (2012) DNA methylation testing and marker validation using PCR: diagnostic applications. Expert Rev Mol Diagn 12:75–92CrossRefPubMedGoogle Scholar
  9. 9.
    Schumacher A, Kapranov P, Kaminsky Z et al (2006) Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res 34:528–542CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Pandey RV, Pulverer W, Kallmeyer R, Beikircher G, Pabinger S, Kriegner A, Weinhðusel A (2016) MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research. Clin Epigenet 8(1):84Google Scholar
  11. 11.
    Pandey RV, Pulverer W, Kallmeyer R, Beikircher G, Pabinger S, Kriegner A, Weinhðusel A (2016) MSP-HTPrimer: a high-throughput primer design tool to improve assay design for DNA methylation analysis in epigenetics. Clin Epigenet 8(1):101Google Scholar
  12. 12.
    Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622CrossRefPubMedGoogle Scholar
  13. 13.
    Devonshire AS, Elaswarapu R, Foy CA (2011) Applicability of RNA standards for evaluating RT-qPCR assays and platforms. BMC Genomics 12:118CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Jackson JB, Choi DS, Luketich JD et al (2016) Multiplex preamplification of serum DNA to facilitate reliable detection of extremely rare cancer mutations in circulating DNA by digital PCR. J Mol Diagn 18:235–243CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Ståhlberg A, Kubista M (2014) The workflow of single-cell expression profiling using quantitative real-time PCR. Expert Rev Mol Diagn 14:323–331CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Pabinger S, Rödiger S, Kriegner A et al (2014) A survey of tools for the analysis of quantitative PCR (qPCR) data. Biomol Detect Quantif 1:23–33CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Wielscher M, Liou W, Pulverer W et al (2013) Cytosine 5-Hydroxymethylation of the LZTS1 gene is reduced in breast cancer. Trans Oncol 6:715–721CrossRefGoogle Scholar
  18. 18.
    Weinhaeusel A, Thiele S, Hofner M et al (2008) PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib. Clin Chem 54:1537–1545CrossRefPubMedGoogle Scholar
  19. 19.
    Andersson D, Akrap N, Svec D et al (2015) Properties of targeted preamplification in DNA and cDNA quantification. Expert Rev Mol Diagn 15:1085–1100CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wielscher M, Pulverer W, Peham J et al (2011) Methyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing. BMC Clin Pathol 11:11CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Pulverer W, Hofner M, Preusser M et al (2014) A simple quantitative diagnostic alternative for MGMT DNA-methylation testing on RCL2 fixed paraffin embedded tumors using restriction coupled qPCR. Clin Neuropathol 33:50–60CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  • Gabriel Beikircher
    • 1
  • Walter Pulverer
    • 1
  • Manuela Hofner
    • 1
  • Christa Noehammer
    • 1
  • Andreas Weinhaeusel
    • 1
  1. 1.Molecular Diagnostics UnitAIT–Austrian Institute of Technology GmbHViennaAustria

Personalised recommendations